Literature DB >> 1560346

Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study.

J Phair1, L Jacobson, R Detels, C Rinaldo, A Saah, L Schrager, A Muñoz.   

Abstract

The objective of this study is to describe participants in the Multicenter AIDS Cohort Study (MACS) with incident infection due to the human immunodeficiency virus type-1 (HIV-1) in whom AIDS developed by March 1990 and within 5 years of seroconversion (group A). Secondly, behavioral, clinical, and immunologic characteristics of these men are compared to those of matched seroconverters remaining AIDS free (group B). Between entry into the MACS (April 1984-March 1985) and July 1989, 345 seronegative homosexual/bisexual men had HIV-1 antibody; of these men, AIDS developed in 32 by March 1990. The Kaplan-Meier estimates of the proportion of men with incident HIV-1 infection with AIDS were 6 months, 0%; 12 months, 1%; 24 months, 3%; and 48 months, 10%. These 32 men engaged in receptive anal intercourse with more partners before (p less than 0.005) and after seroconversion (p less than 0.005) and reported more sexually transmitted disease preseroconversion (p = 0.05) than did group B. These findings suggest that sexually transmitted co-factors, preseroconversion and/or postseroconversion, play a role in the progression of HIV-1 infection. Alternatively, greater sexual activity could increase the hazard of exposure to a more virulent HIV-1 strain.

Entities:  

Mesh:

Year:  1992        PMID: 1560346

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  34 in total

Review 1.  Progression of HIV-infection: markers or determinants.

Authors:  J P Phair; H Farzadegan; J Chmiel; A Muñoz; R Detels; A Saah; R Kaslow
Journal:  Trans Am Clin Climatol Assoc       Date:  1993

2.  Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center.

Authors:  R D Schrier; C A Wiley; C Spina; J A McCutchan; I Grant
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Stability of human immunodeficiency virus RNA in blood specimens as measured by a commercial PCR-based assay.

Authors:  K Sebire; K McGavin; S Land; T Middleton; C Birch
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Increases in duration of first highly active antiretroviral therapy over time (1996-2009) and associated factors in the Multicenter AIDS Cohort Study.

Authors:  Laurence Slama; Xiuhong Li; Todd Brown; Lisa P Jacobson; Gilles Pialoux; Bernard Macatangay; Robert K Bolan; John Phair; Frank J Palella
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731

5.  Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1.

Authors:  Maureen P Martin; Vivek Naranbhai; Patrick R Shea; Ying Qi; Veron Ramsuran; Nicolas Vince; Xiaojiang Gao; Rasmi Thomas; Zabrina L Brumme; Jonathan M Carlson; Steven M Wolinsky; James J Goedert; Bruce D Walker; Florencia P Segal; Steven G Deeks; David W Haas; Stephen A Migueles; Mark Connors; Nelson Michael; Jacques Fellay; Emma Gostick; Sian Llewellyn-Lacey; David A Price; Bernard A Lafont; Phillip Pymm; Philippa M Saunders; Jacqueline Widjaja; Shu Cheng Wong; Julian P Vivian; Jamie Rossjohn; Andrew G Brooks; Mary Carrington
Journal:  J Clin Invest       Date:  2018-04-03       Impact factor: 14.808

6.  Distinct assembly profiles of HLA-B molecules.

Authors:  Syed Monem Rizvi; Nasir Salam; Jie Geng; Ying Qi; Jay H Bream; Priya Duggal; Shehnaz K Hussain; Jeremy Martinson; Steven M Wolinsky; Mary Carrington; Malini Raghavan
Journal:  J Immunol       Date:  2014-04-30       Impact factor: 5.422

7.  Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression.

Authors:  Sher L Hendrickson; James A Lautenberger; Leslie Wei Chinn; Michael Malasky; Efe Sezgin; Lawrence A Kingsley; James J Goedert; Gregory D Kirk; Edward D Gomperts; Susan P Buchbinder; Jennifer L Troyer; Stephen J O'Brien
Journal:  PLoS One       Date:  2010-09-21       Impact factor: 3.240

8.  Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

Authors:  Maureen P Martin; Ying Qi; Xiaojiang Gao; Eriko Yamada; Jeffrey N Martin; Florencia Pereyra; Sara Colombo; Elizabeth E Brown; W Lesley Shupert; John Phair; James J Goedert; Susan Buchbinder; Gregory D Kirk; Amalio Telenti; Mark Connors; Stephen J O'Brien; Bruce D Walker; Peter Parham; Steven G Deeks; Daniel W McVicar; Mary Carrington
Journal:  Nat Genet       Date:  2007-05-13       Impact factor: 38.330

9.  APOBEC3G genetic variants and their influence on the progression to AIDS.

Authors:  Ping An; Gabriela Bleiber; Priya Duggal; George Nelson; Margaret May; Bastien Mangeat; Irene Alobwede; Didier Trono; David Vlahov; Sharyne Donfield; James J Goedert; John Phair; Susan Buchbinder; Stephen J O'Brien; Amalio Telenti; Cheryl A Winkler
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Rapid disease progression in HIV-1 subtype C-infected South African women.

Authors:  Koleka Mlisana; Lise Werner; Nigel J Garrett; Lyle R McKinnon; Francois van Loggerenberg; Jo-Ann S Passmore; Clive M Gray; Lynn Morris; Carolyn Williamson; Salim S Abdool Karim
Journal:  Clin Infect Dis       Date:  2014-07-17       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.